v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:                    
Net income (loss) $ 18 $ 47 $ 21 $ 22 $ (97) $ 61 $ 65 $ (36) $ 7 $ (126)
Adjustments to reconcile net income (loss) to net cash from operating activities:                    
Depreciation and amortization             5 7    
Amortization of right-of-use assets             5 4    
Share-based compensation expense             14 12    
Impairment of tangible and intangible assets             0 8    
Unrealized loss on equity investments             1 1    
Deferred income taxes             7 (24) 7 (64)
Impact from foreign exchange movements             (5) 0    
Other adjustments, net             1 0    
Change in operating assets and liabilities:                    
Accounts receivable             15 (6)    
Current inventories             22 (35) (43) (6)
Other current and non-current assets             31 393 377 (418)
Accrued legal and settlement expenses             (60) (335)    
Other current and non-current liabilities             131 61 8 110
Net cash provided by operating activities             233 51 36 (300)
Cash flows from investing activities:                    
Purchases of property and equipment             (22) (6)    
Purchases of in-process research and development and intangible assets             (1) (1)    
Purchases of investments in debt securities             (11) (9)    
Sales and maturities of debt securities             11 42    
Net cash (used in) provided by investing activities             (22) 26    
Cash flows from financing activities:                    
Proceeds from the issuance of common stock             1 2    
Cash paid for repurchases of common stock             (11) (71)    
Repayments of debt             (8) (1)    
Other             0 (1)    
Settlement of tax on equity awards             (3) (20)    
Net cash used in financing activities             (22) (91)    
Net increase (decrease) in cash and cash equivalents             189 (14)    
Exchange differences             1 0    
Cash and cash equivalents at beginning of period   $ 319   $ 302   $ 316 319 316 316  
Cash and cash equivalents at end of period $ 510   $ 319   $ 302   $ 510 $ 302 $ 319 $ 316